315 related articles for article (PubMed ID: 17956621)
1. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.
Propst-Graham KL; Preheim LC; Vander Top EA; Snitily MU; Gentry-Nielsen MJ
BMC Microbiol; 2007 Oct; 7():94. PubMed ID: 17956621
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae.
Mellencamp MA; Preheim LC
J Infect Dis; 1991 Jan; 163(1):102-8. PubMed ID: 1984456
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Effects of Pneumococcal Extracellular Vesicles on Cellular and Humoral Host Defenses.
Codemo M; Muschiol S; Iovino F; Nannapaneni P; Plant L; Wai SN; Henriques-Normark B
mBio; 2018 Apr; 9(2):. PubMed ID: 29636428
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
Dessing MC; Florquin S; Paton JC; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
[TBL] [Abstract][Full Text] [Related]
5. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
[TBL] [Abstract][Full Text] [Related]
6. The interrelationship between phagocytosis, autophagy and formation of neutrophil extracellular traps following infection of human neutrophils by Streptococcus pneumoniae.
Ullah I; Ritchie ND; Evans TJ
Innate Immun; 2017 Jul; 23(5):413-423. PubMed ID: 28399692
[TBL] [Abstract][Full Text] [Related]
7. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
8. Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.
Alcantara RB; Preheim LC; Gentry MJ
Infect Immun; 1999 Jun; 67(6):2862-6. PubMed ID: 10338492
[TBL] [Abstract][Full Text] [Related]
9. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.
Alcantara RB; Preheim LC; Gentry-Nielsen MJ
Infect Immun; 2001 Jun; 69(6):3569-75. PubMed ID: 11349015
[TBL] [Abstract][Full Text] [Related]
10. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
[TBL] [Abstract][Full Text] [Related]
11. Host cellular immune response to pneumococcal lung infection in mice.
Kadioglu A; Gingles NA; Grattan K; Kerr A; Mitchell TJ; Andrew PW
Infect Immun; 2000 Feb; 68(2):492-501. PubMed ID: 10639409
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
[TBL] [Abstract][Full Text] [Related]
13. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.
Jounblat R; Kadioglu A; Mitchell TJ; Andrew PW
Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.
Salha D; Szeto J; Myers L; Claus C; Sheung A; Tang M; Ljutic B; Hanwell D; Ogilvie K; Ming M; Messham B; van den Dobbelsteen G; Hopfer R; Ochs MM; Gallichan S
Infect Immun; 2012 Jun; 80(6):2212-20. PubMed ID: 22473606
[TBL] [Abstract][Full Text] [Related]
17. The role of pneumolysin in pneumococcal pneumonia and meningitis.
Hirst RA; Kadioglu A; O'callaghan C; Andrew PW
Clin Exp Immunol; 2004 Nov; 138(2):195-201. PubMed ID: 15498026
[TBL] [Abstract][Full Text] [Related]
18. Smoke exposure and ethanol ingestion modulate intrapulmonary polymorphonuclear leukocyte killing, but not recruitment or phagocytosis.
Vander Top EA; Perry GA; Snitily MU; Gentry-Nielsen MJ
Alcohol Clin Exp Res; 2006 Sep; 30(9):1599-607. PubMed ID: 16930223
[TBL] [Abstract][Full Text] [Related]
19. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.
Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L
J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150
[TBL] [Abstract][Full Text] [Related]
20. Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils.
Martner A; Dahlgren C; Paton JC; Wold AE
Infect Immun; 2008 Sep; 76(9):4079-87. PubMed ID: 18559434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
